Chinadaily.com.cn
     
    Go Adv Search

    China's mums key to Nestle baby milk deal

    Updated: 2012-04-25 11:19

    (Agencies)

      Comments() Print Mail Large Medium  Small 分享按鈕 0

    LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

    Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

    Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

    Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

    Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

    The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

    Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

    "The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

    The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

    Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

    Few options for competitors

    The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

    Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

    亚洲高清无码综合性爱视频| 中文字字幕在线一本通| 熟妇人妻中文a∨无码| 亚洲AV永久无码精品网站在线观看 | 亚洲AV无码不卡无码| 色综合久久精品中文字幕首页| 精品无码国产一区二区三区51安 | 久久久久亚洲AV无码专区首JN | 久久久久亚洲AV无码去区首| 亚洲色中文字幕无码AV| 中文字幕一区二区三区5566| 免费无码午夜福利片| 亚洲AV人无码激艳猛片| 无码人妻精品一区二区三区蜜桃| 久久中文字幕人妻熟av女| 2024你懂的网站无码内射| 亚洲av无码一区二区乱子伦as | 成在人线av无码免费高潮喷水| 亚洲欧美日韩在线中文字幕 | A最近中文在线| 久久久久无码国产精品不卡| 久久精品国产亚洲AV无码麻豆 | 久久精品无码一区二区三区免费 | 国产亚洲?V无码?V男人的天堂 | 免费A级毛片无码专区| 日韩精品无码AV成人观看| 中文字幕精品无码一区二区三区| 最近更新中文字幕第一页| 天堂中文在线资源| 亚洲制服中文字幕第一区| 欧美人妻aⅴ中文字幕| 暖暖免费日本在线中文| 亚洲欧美日韩中文在线制服 | 久久丝袜精品中文字幕| 最近2018中文字幕免费视频| 无码AV中文字幕久久专区| 久久久久中文字幕| 中文字幕在线播放| AV无码久久久久不卡蜜桃| 亚洲av中文无码乱人伦在线播放 | 人妻丰满熟妇AV无码区乱|